TRP Channels in Drug Discovery: Volume II
Recent findings have implied a distinct therapeutic potential for drugs targeting Transient Receptor Potential (TRP) channels in a wide variety of diseases, many with no existing satisfactory treatment options. Thus, the TRP superfamily of ion channels has attracted a great deal of well-deserved att...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2012
|
Schriftenreihe: | Methods in Pharmacology and Toxicology
|
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | Recent findings have implied a distinct therapeutic potential for drugs targeting Transient Receptor Potential (TRP) channels in a wide variety of diseases, many with no existing satisfactory treatment options. Thus, the TRP superfamily of ion channels has attracted a great deal of well-deserved attention. TRP Channels in Drug Discovery provides a thorough collection of the most up-to-date reviews and protocols on the subject, coming from top experts in the field. Volume II presents practical methodologies involving models for disorders of the cardiovascular system, the brain, skin, the metabolic system, as well as colitis, cancer, thermosensation, and musculoskeletal disorders. Written for the Methods in Pharmacology and Toxicology™ series, this work includes the kind of detailed description and key implementation advice that ensures successful results in the lab. Comprehensive and cutting-edge, TRP Channels in Drug Discovery serves as an ideal reference for graduate students in academic laboratories as well as for pharmaceutical scientists developing new drugs and clinicians interested in novel drugs in the pipeline |
Beschreibung: | 1 Online-Ressource (XIV, 489 p. 78 illus., 56 illus. in color) |
ISBN: | 9781627030953 |
DOI: | 10.1007/978-1-62703-095-3 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044950803 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 180517s2012 |||| o||u| ||||||eng d | ||
020 | |a 9781627030953 |9 978-1-62703-095-3 | ||
024 | 7 | |a 10.1007/978-1-62703-095-3 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-62703-095-3 | ||
035 | |a (OCoLC)1036366349 | ||
035 | |a (DE-599)BVBBV044950803 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 615 |2 23 | |
245 | 1 | 0 | |a TRP Channels in Drug Discovery |b Volume II |c edited by Arpad Szallasi, Tamás Bíró |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2012 | |
300 | |a 1 Online-Ressource (XIV, 489 p. 78 illus., 56 illus. in color) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Pharmacology and Toxicology | |
520 | |a Recent findings have implied a distinct therapeutic potential for drugs targeting Transient Receptor Potential (TRP) channels in a wide variety of diseases, many with no existing satisfactory treatment options. Thus, the TRP superfamily of ion channels has attracted a great deal of well-deserved attention. TRP Channels in Drug Discovery provides a thorough collection of the most up-to-date reviews and protocols on the subject, coming from top experts in the field. Volume II presents practical methodologies involving models for disorders of the cardiovascular system, the brain, skin, the metabolic system, as well as colitis, cancer, thermosensation, and musculoskeletal disorders. Written for the Methods in Pharmacology and Toxicology™ series, this work includes the kind of detailed description and key implementation advice that ensures successful results in the lab. Comprehensive and cutting-edge, TRP Channels in Drug Discovery serves as an ideal reference for graduate students in academic laboratories as well as for pharmaceutical scientists developing new drugs and clinicians interested in novel drugs in the pipeline | ||
650 | 4 | |a Biomedicine | |
650 | 4 | |a Pharmacology/Toxicology | |
650 | 4 | |a Proteomics | |
650 | 4 | |a Medicine | |
650 | 4 | |a Pharmacology | |
650 | 4 | |a Proteomics | |
700 | 1 | |a Szallasi, Arpad |4 edt | |
700 | 1 | |a Bíró, Tamás |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781627030946 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-62703-095-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030343562 | ||
966 | e | |u https://doi.org/10.1007/978-1-62703-095-3 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-62703-095-3 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178538676355072 |
---|---|
any_adam_object | |
author2 | Szallasi, Arpad Bíró, Tamás |
author2_role | edt edt |
author2_variant | a s as t b tb |
author_facet | Szallasi, Arpad Bíró, Tamás |
building | Verbundindex |
bvnumber | BV044950803 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-62703-095-3 (OCoLC)1036366349 (DE-599)BVBBV044950803 |
dewey-full | 615 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615 |
dewey-search | 615 |
dewey-sort | 3615 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-62703-095-3 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02721nmm a2200457zc 4500</leader><controlfield tag="001">BV044950803</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781627030953</subfield><subfield code="9">978-1-62703-095-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-62703-095-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-62703-095-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1036366349</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044950803</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">TRP Channels in Drug Discovery</subfield><subfield code="b">Volume II</subfield><subfield code="c">edited by Arpad Szallasi, Tamás Bíró</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 489 p. 78 illus., 56 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Pharmacology and Toxicology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Recent findings have implied a distinct therapeutic potential for drugs targeting Transient Receptor Potential (TRP) channels in a wide variety of diseases, many with no existing satisfactory treatment options. Thus, the TRP superfamily of ion channels has attracted a great deal of well-deserved attention. TRP Channels in Drug Discovery provides a thorough collection of the most up-to-date reviews and protocols on the subject, coming from top experts in the field. Volume II presents practical methodologies involving models for disorders of the cardiovascular system, the brain, skin, the metabolic system, as well as colitis, cancer, thermosensation, and musculoskeletal disorders. Written for the Methods in Pharmacology and Toxicology™ series, this work includes the kind of detailed description and key implementation advice that ensures successful results in the lab. Comprehensive and cutting-edge, TRP Channels in Drug Discovery serves as an ideal reference for graduate students in academic laboratories as well as for pharmaceutical scientists developing new drugs and clinicians interested in novel drugs in the pipeline</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteomics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteomics</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Szallasi, Arpad</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bíró, Tamás</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781627030946</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-62703-095-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030343562</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-62703-095-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-62703-095-3</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV044950803 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:05:34Z |
institution | BVB |
isbn | 9781627030953 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030343562 |
oclc_num | 1036366349 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XIV, 489 p. 78 illus., 56 illus. in color) |
psigel | ZDB-2-PRO |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Humana Press |
record_format | marc |
series2 | Methods in Pharmacology and Toxicology |
spelling | TRP Channels in Drug Discovery Volume II edited by Arpad Szallasi, Tamás Bíró Totowa, NJ Humana Press 2012 1 Online-Ressource (XIV, 489 p. 78 illus., 56 illus. in color) txt rdacontent c rdamedia cr rdacarrier Methods in Pharmacology and Toxicology Recent findings have implied a distinct therapeutic potential for drugs targeting Transient Receptor Potential (TRP) channels in a wide variety of diseases, many with no existing satisfactory treatment options. Thus, the TRP superfamily of ion channels has attracted a great deal of well-deserved attention. TRP Channels in Drug Discovery provides a thorough collection of the most up-to-date reviews and protocols on the subject, coming from top experts in the field. Volume II presents practical methodologies involving models for disorders of the cardiovascular system, the brain, skin, the metabolic system, as well as colitis, cancer, thermosensation, and musculoskeletal disorders. Written for the Methods in Pharmacology and Toxicology™ series, this work includes the kind of detailed description and key implementation advice that ensures successful results in the lab. Comprehensive and cutting-edge, TRP Channels in Drug Discovery serves as an ideal reference for graduate students in academic laboratories as well as for pharmaceutical scientists developing new drugs and clinicians interested in novel drugs in the pipeline Biomedicine Pharmacology/Toxicology Proteomics Medicine Pharmacology Szallasi, Arpad edt Bíró, Tamás edt Erscheint auch als Druck-Ausgabe 9781627030946 https://doi.org/10.1007/978-1-62703-095-3 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | TRP Channels in Drug Discovery Volume II Biomedicine Pharmacology/Toxicology Proteomics Medicine Pharmacology |
title | TRP Channels in Drug Discovery Volume II |
title_auth | TRP Channels in Drug Discovery Volume II |
title_exact_search | TRP Channels in Drug Discovery Volume II |
title_full | TRP Channels in Drug Discovery Volume II edited by Arpad Szallasi, Tamás Bíró |
title_fullStr | TRP Channels in Drug Discovery Volume II edited by Arpad Szallasi, Tamás Bíró |
title_full_unstemmed | TRP Channels in Drug Discovery Volume II edited by Arpad Szallasi, Tamás Bíró |
title_short | TRP Channels in Drug Discovery |
title_sort | trp channels in drug discovery volume ii |
title_sub | Volume II |
topic | Biomedicine Pharmacology/Toxicology Proteomics Medicine Pharmacology |
topic_facet | Biomedicine Pharmacology/Toxicology Proteomics Medicine Pharmacology |
url | https://doi.org/10.1007/978-1-62703-095-3 |
work_keys_str_mv | AT szallasiarpad trpchannelsindrugdiscoveryvolumeii AT birotamas trpchannelsindrugdiscoveryvolumeii |